Eric Winzer

Eric Winzer has extensive experience as a CFO, having held this role at Immunomic Therapeutics, Inc., OpGen, Avalon Pharmaceuticals, and Invitrogen. Eric also served as the Audit Committee Chair at Nuo Therapeutics, Inc. Eric joined Invitrogen in 2001 and remained as the CFO until 2006. In 2007, they joined Avalon Pharmaceuticals as the CFO, leaving the position in 2009 to take on the role of CFO at OpGen. In 2014, they became the Audit Committee Chair at Nuo Therapeutics, Inc. and in 2015, they became the CFO at Immunomic Therapeutics, Inc.

Eric Winzer attended Mount St. Mary's University where they pursued an MBA with a focus on Finance. However, there is no information available regarding the start or end years of their education at this institution.